<?xml version = "1.0" encoding = "UTF-8" ?>
<Project>
	<ProjectTitle>CTN Dissemination Library [no.87]: A 
										Multi-Center Randomized Trial of Buprenorphine-Naloxone Versus 
										Clonidine for Opioid Detoxification: Findings from the National 
										Institute on Drug Abuse Clinical Trials Network
	</ProjectTitle>

	<CitationSet>
		<Citation>
			<CitationType>Current</CitationType>
			<PMID>16042639</PMID>
			<DOI>10.1111/j.1360-0443.2005.01154.x%20</DOI>   
			<PMCID>PMC1480367</PMCID> 
			<JournalCitation>
					<JournalName>Addiction</JournalName>
					<JournalYear>2005</JournalYear>
					<JournalIssue>100</JournalIssue>
					<JournalNumber>8</JournalNumber>
					<PageSet>
						<PageStart>1090</PageStart>
						<PageEnd>1100</PageEnd>
					</PageSet>
			</JournalCitation>
		</Citation>
		<Citation>
			<CitationType>Correction</CitationType>
					<JournalCitation>
						<JournalName>Addiction</JournalName>
						<JournalYear>2006</JournalYear>
						<JournalIssue>101</JournalIssue>
						<JournalNumber>9</JournalNumber>
						<PageSet>
							<PageStart>1374</PageStart>
							<PageEnd>1374</PageEnd>
						</PageSet>
					</JournalCitation>
				</Citation>
			</CitationSet>

	<AuthorSet>
		<Author>
			<Name>Walter Ling</Name> 
				<DegreeSet>
					<Degree>MD</Degree>
				</DegreeSet>
				<AffiliationSet>
				<Affiliation>Integrated Substance Abuse Programs, UCLA, PR Node</Affiliation>
				</AffiliationSet>
			</Author> 
		<Author>
		<Name>Leslie Amass</Name>
		<DegreeSet>
			<Degree> PhD</Degree>
		</DegreeSet>
		<AffiliationSet>
		<Affiliation>Friends Research Institute, PR Node </Affiliation>
		</AffiliationSet>
		</Author>
		<Author>
		<Name>Steven Shoptaw</Name>
		<DegreeSet>
			<Degree> PhD</Degree>
		</DegreeSet>
		<AffiliationSet>
		<Affiliation>Integrated Substance Abuse Programs, UCLA, PR Node </Affiliation>
		</AffiliationSet>
		</Author>
		<Author>
		<Name>Jeffrey J. Annon </Name> 
		<DegreeSet>
			<Degree>MA</Degree>
		</DegreeSet>
		<AffiliationSet>
		<Affiliation>Integrated Substance Abuse Programs, UCLA, PR Node</Affiliation>
		</AffiliationSet>
		</Author>
		<Author>
		<Name>Maureen Hillhouse</Name>
		<AffiliationSet>
		<Affiliation>Integrated Substance Abuse Programs, UCLA, PR Node</Affiliation>
		</AffiliationSet>
		</Author>
		<Author> 
			<Name>Dean Babcock</Name> 
			<DegreeSet> 
				<Degree> MSW</Degree>
			</DegreeSet>
		<AffiliationSet>
		<Affiliation>Midtown Community Health Center, OV Node</Affiliation>
		</AffiliationSet>
		</Author> 
		<Author>
		<Name>Gregory S. Brigham</Name>
		<DegreeSet> 
			<Degree>PhD</Degree>
		</DegreeSet>
		<AffiliationSet>
		<Affiliation> Maryhaven, Inc, OV Node</Affiliation>
		</AffiliationSet>
		</Author> 
		<Author>
		<Name>Judith Harrer</Name>
		<DegreeSet>
			<Degree>PhD</Degree>
		</DegreeSet>
		<AffiliationSet>
		<Affiliation> VA Medical Center, OV Node</Affiliation>
		</AffiliationSet>
		</Author>
		<Author>
		<Name>Malcolm S. Reid</Name>
		<DegreeSet>
			<Degree>PhD</Degree>
		</DegreeSet>
		<AffiliationSet>
		<Affiliation>NYU School of Medicine, NY Node</Affiliation>
		</AffiliationSet>
		</Author>
		<Author>
		<Name>Joan A. Muir</Name> 
		<DegreeSet>
			<Degree>PhD</Degree>
		</DegreeSet>
		<AffiliationSet>
		<Affiliation>Center for Family Studies, U of Miami, FL Node</Affiliation>
		</AffiliationSet>
		</Author>
		<Author>
		<Name>Betty J. Buchan</Name> 
		<DegreeSet>
		<Degree>PhD</Degree>
		</DegreeSet>
		<AffiliationSet>
		<Affiliation>Operation PAR, Inc., FL Node</Affiliation>
		</AffiliationSet>
		</Author>
		<Author>
		<Name>Deborah Orr</Name> 
		<DegreeSet>
			<Degree>PhD</Degree>
		</DegreeSet>
		<AffiliationSet>
		<Affiliation>Center for Drug-Free Living, FL Node</Affiliation>
		</AffiliationSet>
		</Author> 
		<Author>
		<Name>George E. Woody</Name> 
		<DegreeSet>
			<Degree>MD</Degree>
		</DegreeSet>
		<AffiliationSet>
		<Affiliation>University of Pennsylvania, DV Node</Affiliation>
		</AffiliationSet>
		</Author>
		<Author>
		<Name>Jonathan Krejci</Name> 
		<DegreeSet>
			<Degree>PhD</Degree>
		</DegreeSet>
		<AffiliationSet>
		<Affiliation>Mercer Trenton Addiction Science Center, DV Node</Affiliation>
		</AffiliationSet>
		</Author> 
		<Author>
		<Name>Douglas M. Ziedonis</Name> 
		<DegreeSet>
			<Degree>MD</Degree> 
			<Degree>MPH</Degree>
		</DegreeSet>
		<AffiliationSet>
		<Affiliation>Robert Wood Johnson Medical Center, DV Node</Affiliation>
		</AffiliationSet>
		</Author> 
		<Author>
		<Name>CTN Buprenorphine Study Team (CTN-0001/0002)</Name>
		</Author>
	</AuthorSet>


	<ProjectDescription>
		<Abstract>
			<Background>This is the Primary Outcomes Article for CTN-0001 and CTN-0002. The clinical effectiveness of buprenorphine-naloxone (bup-nx) and clonidine for opioid detoxification in inpatient and outpatient community treatment programs was investigated in the first studies of the National Institute of Drug Abuse Clinical Trials Network. 
			</Background>  
	<PopulationSpecification>
		<Enrollment>
			<CriterionSet>
				<Criterion>
					<CriterionType>Inclusion</CriterionType>
					<CriterionSpecification>DSM-IV diagnosis of opioid dependence</CriterionSpecification>
				</Criterion>
				<Criterion>
					<CriterionType>Inclusion</CriterionType>
					<CriterionSpecification>Seeking Treatment</CriterionSpecification>
				</Criterion>
				<Criterion>
					<CriterionType>Inclusion</CriterionType>
					<CriterionSpecification>Outpatient or Inpatient</CriterionSpecification>
				</Criterion>
			</CriterionSet>
		</Enrollment>
		<Allocation>
	   <!-- 
				Consider an allocation to be a partition over the enrolled population. 
				Just as with enrollment, allocation descends from partition and so must 
				inherit the following attributes: 

					Predicate: If true go to group A else go to not group A
					In the future I will have to generalize this to account for study designs that
					 1: Have crossover
					 2: Have more than two study arms

	   -->
			<AllocationPredicate>
				<AllocationPredicateFunction>
					<AllocationPredicateFunctionSignature>rand</AllocationPredicateFunctionSignature>
					<AllocationPredicateFunctionArgumentSet>
							<AllocationPredicateFunctionArgument>
								<AllocationPredicateFunctionArgumentName>weight</AllocationPredicateFunctionArgumentName>
								<AllocationPredicateFunctionArgumentValue>2</AllocationPredicateFunctionArgumentValue>
							</AllocationPredicateFunctionArgument>
					</AllocationPredicateFunctionArgumentSet>
				</AllocationPredicateFunction>
				<AllocationPredicateValueIfTrue>Assign to Administered Buprenorphine/Naloxone</AllocationPredicateValueIfTrue>
				<AllocationPredicateValueIfFalse>Assign to Administered Clonidine</AllocationPredicateValueIfFalse>
			</AllocationPredicate>
		<!-- 
					Something seems off about a file containing a generic dependent continuant and the application of that generic dependent continuant to a population. Something about mixing types? 
					Don't let perfect be the enemy of good. -->
		</Allocation>
		<AllocatedStudyArmSet>
			<AllocatedStudyArm>
				<Name>Administered Buprenorphine and Naloxone</Name>
				<InitialSize>
					<SubgroupSet>
						<Subgroup>
							<Name>Inpatient</Name>
							<Size>77</Size>
						</Subgroup>
						<Subgroup>
							<Name>Outpatient</Name>
							<Size>157</Size>
						</Subgroup>
					</SubgroupSet>
					</InitialSize>
				<InterventionSet>
					<Intervention>Administration of Buprenorphine and Naloxone</Intervention>
				</InterventionSet>
				<MetricResultSet>
					<MetricResult>An outcome measure here</MetricResult>
				</MetricResultSet>
			</AllocatedStudyArm>
			<AllocatedStudyArm>
				<Name>Administered Clonidine</Name>
				<InitialSize>
					<SubgroupSet>
						<Subgroup>
							<Name>Inpatient</Name>
							<Size>36</Size>
						</Subgroup>
					<Subgroup>
						<Name>Outpatient</Name>
						<Size>74</Size>
					</Subgroup>
					</SubgroupSet>
				</InitialSize>
				<InterventionSet>
					<Intervention>Administration of Clonidine</Intervention>
				</InterventionSet>
			</AllocatedStudyArm>
		</AllocatedStudyArmSet>
	</PopulationSpecification>

	<!-- Generalization of I,C in PICO -->
	<!-- I.e. what you did to the population -->
	<PlannedActionSet>
		<PlannedAction>
			<Name>Administration of Clonidine</Name>
			<IntendedTargetPopulation>Administered Clonidine</IntendedTargetPopulation>
			<PlannedActionSpecification>
				<TypeOfAction>Drug Administration</TypeOfAction>
				<DrugAdministrationScheduleSet>
					<DrugAdministrationSchedule>
						<Substance>Clonidine</Substance>
						<Duration>?</Duration>
						<Frequency>?</Frequency>
						<Dose>?</Dose>
					</DrugAdministrationSchedule>
				</DrugAdministrationScheduleSet>
				<DurationOfAction></DurationOfAction>
				<!-- Type Specific Fields -->
		</PlannedActionSpecification>
		</PlannedAction>

		<PlannedAction>
			<Name>Administration of Buprenorphine and Naloxone</Name>
			<IntendedTargetPopulation>Administered Buprenorphine and Naloxone</IntendedTargetPopulation>
			<PlannedActionSpecification>
				<TypeOfAction>Drug Administration</TypeOfAction>
					<DrugAdministrationScheduleSet>
						<!-- Be careful about using sets. Sets have no intrinsic ordering. I am unclear what a set of generically dependent continuants means -->
					<DrugAdministrationSchedule>
							<Substance>Buprenorphine/Naloxone</Substance>
							<Duration>?</Duration>
							<Frequency>?</Frequency>
							<Dose>?</Dose>
					</DrugAdministrationSchedule>
				</DrugAdministrationScheduleSet>
				<DurationOfAction></DurationOfAction>
				<!-- Type Specific Fields -->
			</PlannedActionSpecification>
		</PlannedAction>
	</PlannedActionSet>

	<MetricSpecificationSet>
		<MetricSpecification>
			<Name>Urine Screen</Name>
			<Measurement>
				<MeasurementName>Concentration of compound in urine</MeasurementName>
				<MeasurementUnits>ng/mL</MeasurementUnits>
			</Measurement> 
			<IntendedTargetPopulationSet>
				<IntendedTargetPopulation>
					<Name>Administered Buprenorphine and Naloxone</Name>
					<Value></Value>
				</IntendedTargetPopulation>
				<IntendedTargetPopulation>Administered Clonidine</IntendedTargetPopulation>
			</IntendedTargetPopulationSet>
			<StatisticSpecification>
					<StatisticName></StatisticName>
					<ModifierSet>
						<Modifier></Modifier>
					</ModifierSet>
					<FalsePositiveChance></FalsePositiveChance>
			</StatisticSpecification>
		</MetricSpecification>
		<MetricSpecification>
			<IntendedTargetPopulationSet>
				<IntendedTargetPopulation>Administered Buprenorphine and Naloxone</IntendedTargetPopulation>
				<IntendedTargetPopulation>Administered Clonidine</IntendedTargetPopulation>
			</IntendedTargetPopulationSet>
			<Name>Use of Ancillary Medications</Name>
			<Measurement>
				<MeasurementName>Number of Ancillary Medicine Used</MeasurementName>
				<MeasurementUnits>None</MeasurementUnits>
			</Measurement>
			<StatisticSpecification>
				<StatisticName></StatisticName>
					<ModifierSet>
						<Modifier></Modifier>
					</ModifierSet>
					<FalsePositiveChance></FalsePositiveChance>
			</StatisticSpecification>
		</MetricSpecification>
		<MetricSpecification>
			<IntendedTargetPopulationSet>
				<IntendedTargetPopulation>Administered Buprenorphine and Naloxone</IntendedTargetPopulation>
				<IntendedTargetPopulation>Administered Clonidine</IntendedTargetPopulation>
			</IntendedTargetPopulationSet>
				<Name>Number of Side Effects Reported</Name>
				<Measurement>
					<MeasurementName>Count</MeasurementName>
					<MeasurementUnits>None</MeasurementUnits>
				</Measurement>
				<StatisticSpecification>
					<StatisticName></StatisticName>
					<ModifierSet>
						<Modifier></Modifier>
					</ModifierSet>
					<FalsePositiveChance></FalsePositiveChance>
				</StatisticSpecification>
		</MetricSpecification>
		<MetricSpecification>
			<IntendedTargetPopulationSet>
				<IntendedTargetPopulation>Administered Buprenorphine and Naloxone</IntendedTargetPopulation>
				<IntendedTargetPopulation>Administered Clonidine</IntendedTargetPopulation>
			</IntendedTargetPopulationSet>
			<Name>Withdrawal Rating</Name>
			<Measurement>
				<MeasurementName>Patient Ranking on Standardized Scale</MeasurementName>
				<MeasurementUnits>None</MeasurementUnits>
			</Measurement>
			<StatisticSpecification>
				<StatisticName></StatisticName>
				<ModifierSet>
					<Modifier></Modifier>
				</ModifierSet>
				<FalsePositiveChance></FalsePositiveChance>
			</StatisticSpecification>
		</MetricSpecification>
		 <MetricSpecification>
			<IntendedTargetPopulationSet>
				<IntendedTargetPopulation>Administered Buprenorphine and Naloxone</IntendedTargetPopulation>
				<IntendedTargetPopulation>Administered Clonidine</IntendedTargetPopulation>
			</IntendedTargetPopulationSet>
			<Name>Craving Rating</Name>
				<Measurement>
				<MeasurementName>Patient Ranking on Standardized Scale</MeasurementName>
				<MeasurementUnits>None</MeasurementUnits>
			</Measurement>
			<StatisticSpecification>
				<StatisticName></StatisticName>
				<ModifierSet>
					<Modifier></Modifier>
				</ModifierSet>
				<FalsePositiveChance></FalsePositiveChance>
			</StatisticSpecification>
		</MetricSpecification>
	</MetricSpecificationSet>

<MetricResultSet>
	<!-- More general way of writing outcomes -->
	<MetricResult>
			<MetricName>Urine Screen</MetricName>
					<StudyArmSet>
						<StudyArm>
								<Name>Administered Buprenorphine and Naloxone</Name>
								<MetricValue>X</MetricValue>
					</StudyArm>
					<StudyArm>
							<Name>Administered Clonidine</Name>
							<MetricValue>X</MetricValue>
					</StudyArm>
					</StudyArmSet>
		</MetricResult>
		<MetricResult>			
			<MetricName>Number of Side Effects Reported</MetricName>
				<StudyArmSet>
					<StudyArm>
						<Name>Administered Buprenorphine and Naloxone</Name>
						 <MetricValue>X</MetricValue>
					 </StudyArm>
					 <StudyArm>
						<Name>Administered Clonidine</Name>
						<MetricValue>x</MetricValue>
					</StudyArm>
				</StudyArmSet>
			</MetricResult>
					<MetricResult>			
			<MetricName>Withdrawal Rating</MetricName>
				<StudyArmSet>
					<StudyArm>
						<Name>Administered Buprenorphine and Naloxone</Name>
						 <MetricValue>X</MetricValue>
					 </StudyArm>
					 <StudyArm>
						<Name>Administered Clonidine</Name>
						<MetricValue>x</MetricValue>
					</StudyArm>
				</StudyArmSet>
			</MetricResult>
					<MetricResult>			
			<MetricName>Craving Rating</MetricName>
				<StudyArmSet>
					<StudyArm>
						<Name>Administered Buprenorphine and Naloxone</Name>
						 <MetricValue>X</MetricValue>
					 </StudyArm>
					 <StudyArm>
						<Name>Administered Clonidine</Name>
						<MetricValue>x</MetricValue>
					</StudyArm>
				</StudyArmSet>
			</MetricResult>
		</MetricResultSet>

				<AbstractText>
					DSM-IV-diagnosed opioid-dependent individuals seeking short-term treatment were randomly assigned, in a 2:1 ratio favoring bup-nx, to a 13-day detoxification using bup-nx or clonidine. A total of 113 inpatients (77 bup-nx, 36 clonidine) and 231 outpatients (157 bup-nx, 74 clonidine) participated. Supportive interventions included appropriate ancillary medications and standard counseling procedures defined as the proportion of participants in each condition who were both retained in the study for the entire duration and provided an opioid-free urine sample on the last day of clinic attendance. Secondary outcome measures included use of ancillary medications, number of side effects reported and withdrawal and craving ratings. A total of 59 of the 77 (77%) inpatients assigned to the bup-nx condition achieved the treatment success criterion compared to 8 of the 36 (22%) assigned to clonidine, whereas 46 of the 157 (29%) outpatients assigned to the bup-nx condition achieved the treatment success criterion, compared to 74 (5%) assigned to clonidine.
				</AbstractText>
		</Abstract>

		<Conclusion>The benefits of bup-nx for opioid detoxification are supported and illustrate important ways in which clinical research can be conducted in community treatment programs. </Conclusion>

		<KeywordSet>
			<Keyword>Buprenorphine/Naloxone</Keyword> 
			<Keyword>Clonidine</Keyword> 
			<Keyword>Effectiveness Trials</Keyword>
			<Keyword>CTN Primary Outcomes</Keyword>
			<Keyword>Opioid Dependency</Keyword>
			<Keyword>Opioid Detoxification</Keyword>
			<Keyword>Pharmacologic Therapy</Keyword>
			<Keyword>Suboxone</Keyword>
	</KeywordSet>

	</ProjectDescription>
						
	<ProtocolSet>
		<Protocol>
			<Name>NIDA-CTN-0001</Name>
			<Detail>
				<Url>http://ctndisseminationlibrary.org/protocols/ctn0001.htm</Url>
			</Detail>
		</Protocol>
		<Protocol>
			<Name>NIDA-CTN-0002</Name>
			<Detail>
				<Url>http://ctndisseminationlibrary.org/protocols/ctn0002.htm
				</Url>
			</Detail>
		</Protocol>
	</ProtocolSet>

		<ParticipatingNodeSet>
			<ParticipatingNode>
				<Name>Pacific Region</Name>
				<Role>Lead</Role>
			</ParticipatingNode>

			<ParticipatingNode>
				<Name>Delaware Valley</Name> 
			</ParticipatingNode>

			<ParticipatingNode>
				<Name>Great Lakes Regional</Name> 
			</ParticipatingNode>

			<ParticipatingNode>
				<!-- Need to think about relationships between names, placeholder as with many things for now -->
				<Name>Greater New York</Name> 
				<AlternateName>Long Island and New York</AlternateName>

		 </ParticipatingNode>
		 <ParticipatingNode>
			<Name>Florida Node Alliance</Name>
		</ParticipatingNode>

		<ParticipatingNode>
			<Name>Ohio Valley</Name>
		</ParticipatingNode>

		<ParticipatingNode>
			<Name>Western States</Name> 
			<AlternateName>Oregon/Hawaii</AlternateName>
		</ParticipatingNode>
	</ParticipatingNodeSet>
</Project>